Procalcitonin Interpreter
Procalcitonin Interpreter
Read a procalcitonin result against the bacterial-infection thresholds used in antibiotic stewardship, and see where it misleads.
Procalcitonin
PCT → bacterial likelihoodProcalcitonin 0.35 ng/mL
Interpretation bands
0.25 – 0.49 — slightly raised
0.5 – 1.99 — raised
2 – 9.99 — high
≥ 10 — very high
- kinetics
- rises within 3–6 hours of bacterial infection, peaks at 12–24 hours, falls with a half-life of about 24 hours
- trend
- a fall of more than 80% from peak supports stopping antibiotics — more informative than any single value
- best evidence
- antibiotic stewardship in lower respiratory tract infection and sepsis, where PCT-guided algorithms reduce antibiotic duration without increasing mortality
Worked example
Procalcitonin 0.35 ng/mL
0.35 is 0.25 or above but under 0.5 → slightly raised
A single value here is less useful than the trend — repeat and compare against the peak
Interpretation thresholds
| PCT (ng/mL) | Interpretation | Likely infection |
|---|---|---|
| < 0.25 | Low | Bacterial infection unlikely |
| 0.25 – 0.49 | Slightly raised | Bacterial infection less likely |
| 0.5 – 1.99 | Raised | Bacterial infection possible |
| 2 – 9.99 | High | Systemic bacterial infection likely |
| ≥ 10 | Very high | Severe bacterial sepsis likely |
Why the trend matters more than the number
Procalcitonin rises within 3 to 6 hours of a bacterial infection, peaks at 12 to 24 hours, and falls with a half-life of around 24 hours once the infection is controlled — kinetics that make the trend far more informative than a single value. A fall of more than 80% from the peak is the threshold most commonly used to support stopping antibiotics.
Its best-evidenced use is antibiotic stewardship in lower respiratory tract infection and sepsis, where procalcitonin-guided algorithms have been shown to reduce the duration of antibiotic treatment without increasing mortality, in several large trials and meta-analyses.
Its limits need to be stated plainly. Procalcitonin is raised, sometimes markedly, by major surgery, trauma, burns, cardiogenic shock, acute pancreatitis, medullary thyroid carcinoma and after anti-lymphocyte antibody therapy — all without bacterial infection. It reads lower than expected in localised infection such as an empyema or an abscess, where systemic release is limited. And it is unreliable in the first 48 hours of life, when levels are physiologically raised regardless of infection.
It must never override clinical judgement. A low procalcitonin in a patient who is clinically septic does not justify withholding or delaying antibiotics — treat the patient in front of you, and use the number to support that judgement, not replace it.
Frequently asked questions
What procalcitonin level suggests bacterial infection?
Above 0.5 ng/mL suggests possible bacterial infection, and above 2 ng/mL suggests it is likely. Below 0.25 ng/mL, bacterial infection is unlikely, though the trend matters more than any single value.
Why does the trend matter more than one result?
Procalcitonin rises within hours of bacterial infection and falls with a roughly 24-hour half-life once it is controlled. A fall of more than 80% from the peak supports stopping antibiotics, which a single value cannot show.
What else raises procalcitonin besides bacterial infection?
Major surgery, trauma, burns, cardiogenic shock, pancreatitis, medullary thyroid carcinoma and anti-lymphocyte antibody treatment can all raise it without infection being present.
Can a low procalcitonin rule out sepsis?
No. It must never override clinical judgement — a low value in a patient who looks clinically septic does not justify withholding or delaying antibiotics. It is also less reliable in localised infections such as an abscess or empyema.
Related calculators
References
- Schuetz P et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107.
- Evans L et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063–143.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.